Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,633 | 5,586 | 2,667 | 11,378 | 8,378 |
| Depreciation Amortization | 2,359 | 1,560 | 775 | 3,356 | 2,538 |
| Income taxes - deferred | -359 | -213 | -131 | -500 | -414 |
| Accounts receivable | -791 | -828 | -432 | -365 | -291 |
| Accounts payable and accrued liabilities | 31 | 5 | -106 | 188 | 258 |
| Other Working Capital | -796 | -1,236 | -1,091 | 1,071 | 329 |
| Other Operating Activity | 818 | 859 | 561 | 259 | 60 |
| Operating Cash Flow | $9,895 | $5,733 | $2,243 | $15,387 | $10,858 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -151 | -109 | -68 | -1,110 | -953 |
| Purchase Sale Intangibles | -55 | -7 | -2 | -22 | 0 |
| Other Investing Activity | -55 | -7 | -2 | -22 | 0 |
| Investing Cash Flow | $-206 | $-116 | $-70 | $-1,132 | $-953 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,778 | -4,778 | -4,778 | -4,035 | -3,052 |
| Common Stock Issued | 298 | 245 | 72 | 491 | 361 |
| Common Stock Repurchased | -683 | -215 | N/A | -1,055 | -1,017 |
| Dividend Paid | -1,914 | -957 | N/A | -3,765 | -1,874 |
| Other Financing Activity | 68 | 65 | 17 | 103 | 139 |
| Financing Cash Flow | $-7,009 | $-5,640 | $-4,689 | $-8,261 | $-5,443 |
| Exchange Rate Effect | -332 | -82 | -656 | -1,115 | -609 |
| Beginning Cash Position | 19,274 | 19,274 | 19,274 | 14,395 | 14,395 |
| End Cash Position | 21,622 | 19,169 | 16,102 | 19,274 | 18,248 |
| Net Cash Flow | $2,348 | $-105 | $-3,172 | $4,879 | $3,853 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,895 | 5,733 | 2,243 | 15,387 | 10,858 |
| Capital Expenditure | -151 | -109 | -68 | -1,110 | -953 |
| Free Cash Flow | 9,744 | 5,624 | 2,175 | 14,277 | 9,905 |